Related references
Note: Only part of the references are listed.From α-synuclein to synaptic dysfunctions: New insights into the pathophysiology of Parkinson's disease
Arianna Bellucci et al.
BRAIN RESEARCH (2012)
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Nunilo Cremades et al.
CELL (2012)
Semisynthetic, Site-Specific Ubiquitin Modification of α-Synuclein Reveals Differential Effects on Aggregation
Franziska Meier et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Elucidating the Role of C-Terminal Post-Translational Modifications Using Protein Semisynthesis Strategies: α-Synuclein Phosphorylation at Tyrosine 125
Mirva Hejjaoui et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2012)
Towards Elucidation of the Role of Ubiquitination in the Pathogenesis of Parkinson's Disease with Semisynthetic Ubiquitinated alpha-Synuclein
Mirva Hejjaoui et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases
Derrick Sek Tong Ong et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method
Annika Ohrfelt et al.
NEUROCHEMICAL RESEARCH (2011)
The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine
John A. Hanover et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages
Per Borghammer et al.
BRAIN STRUCTURE & FUNCTION (2010)
Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits α-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions
Katerina E. Paleologou et al.
JOURNAL OF NEUROSCIENCE (2010)
Enrichment and Site Mapping of O-Linked N-Acetylglucosamine by a Combination of Chemical/Enzymatic Tagging, Photochemical Cleavage, and Electron Transfer Dissociation Mass Spectrometry
Zihao Wang et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
Bin Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Aggregation-defective α-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked α-synuclein variants
Hyun-Jung Koo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
β-Sheet-breaking peptides inhibit the fibrillation of human α-synuclein
You Soon Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Tonicity-dependent induction of Sgk1 expression has a potential role in dehydration-induced natriuresis in rodents
Songcang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Interplay of α-synuclein binding and conformational switching probed by single-molecule fluorescence
Allan Chris M. Ferreon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc)
Donald A. R. Sinclair et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
New Insights into Metabolic Signaling and Cell Survival: The Role of β-O-Linkage of N-Acetylglucosamine
Gladys A. Ngoh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2008)
Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins
Gerald W. Hart et al.
NATURE (2007)
The aggregation and fibrillation of α-synuclein
Anthony L. Fink
ACCOUNTS OF CHEMICAL RESEARCH (2006)
Acceleration of α-synuclein aggregation by homologous peptides
Hai-Ning Du et al.
FEBS LETTERS (2006)
Genetics of Parkinson disease: paradigm shifts and future prospects
MJ Farrer
NATURE REVIEWS GENETICS (2006)
Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
WX Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress -: A survival response of mammalian cells
NE Zachara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study
A Drzezga et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Simplifying oligosaccharide synthesis: Efficient synthesis of lactosamine and siaylated lactosamine oligosaccharide donors
FY Yan et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
Microscopic analysis of polymerization dynamics with individual actin filaments
I Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Ubiquitination of a new form of α-synuclein by parkin from human brain:: Implications for Parkinson's disease
H Shimura et al.
SCIENCE (2001)
Solid-phase synthesis of O-linked glycopeptide analogues of enkephalin
SA Mitchell et al.
JOURNAL OF ORGANIC CHEMISTRY (2001)
The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny
R Shafi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
α-Synuclein immunoreactivity in dementia with Lewy bodies:: morphological staging and comparison with ubiquitin immunostaining
E Gómez-Tortosa et al.
ACTA NEUROPATHOLOGICA (2000)
Share Paper
